Naltrexone has variable and schedule-dependent effects on oral squamous cell carcinoma cells
Sahar Kazmi, Erica Sanford, Zaid A. Rammaha, Ethan J. Bengson, Feng Gao, Linda Sangalli, Cai M. Roberts
This study investigates the effects of naltrexone on oral squamous cell carcinoma cells, finding that it has minimal impact alone but may enhance chemotherapy effectiveness when combined.
International Journal of Molecular Sciences · Nov 1, 2025Peer-reviewedPharmacology & Toxicology